Medicinal mushrooms refer to a type of mushroom with medicinal value. Specifically, it refers to mushrooms that produce various active ingredients in their mycelium, fruiting bodies, sclerotia, or spores that have health benefits for the human body, as well as preventive, inhibitory, or therapeutic effects on diseases. These components may include amino acids, proteins, polysaccharides, alkaloids, etc.

There are many types of medicinal mushrooms, which can be divided into anti-tumor, immune regulating, antibacterial and anti-inflammatory categories according to their functions. Common medicinal mushrooms include Ganoderma lucidum, Cordyceps sinensis, Poria cocos, Yunzhi, etc. These mushrooms not only have wide applications in traditional medicine, but modern scientific research has also confirmed their various pharmacological effects.

Overview of Market Development

Medicinal mushrooms, as natural medicinal resources, have unique healthcare value and are an important source for developing new drugs and health products. In recent years, with the increasing awareness of consumer health, the demand for natural and plant-based supplements has continued to rise, driving the development of the medicinal mushroom market. However, the market also faces challenges from the lack of standardized regulations and insufficient scientific verification of health claims.

According to our research data, the estimated revenue of the global medicinal mushroom market in 2024 is $311 million, an increase of 5.56% compared to 2023. In the future, with the expansion of the health industry, medicinal mushrooms will be included in more products. In addition, with the increasing improvement of relevant regulations, it is expected that the market will gradually become standardized. By 2029, the revenue of the global medicinal mushroom market may increase to $409 million. The CAGR for 2024-2029 is estimated to be 5.63%.

Segmented Market Analysis

From the perspective of product types, medicinal mushrooms can be divided into two categories based on their appearance and properties: powder and liquid. Among them, powder products dominate the market, with an estimated market share of 87.51% in 2024.

Source: www.globalmarketmonitor.com

Market Competition Pattern

From the perspective of market competition, the concentration of the global medicinal mushroom market is low. Data shows that in 2023, the top 3 companies had a total revenue of $70.26 million in the medicinal mushroom market, with a total revenue share of only 23.82%; The total revenue of the top 6 enterprises was 101.47 million, with a total revenue share of only 34.40%. The top 3 companies were GanoHerb, Zhongke Health Industry Group Corp., Ltd., and Aloha Medicinals. In 2023, these three companies accounted for 9.47%, 7.99%, and 6.36% of the global mushroom market revenue, respectively.

Companies	Market Revenue (Million USD)	Revenue Share
GanoHerb	2793	9.47%
Zhongke Health Industry Group Corp., Ltd.	2357	7.99%
Aloha Medicinals	1876	6.36%
Top3 Companies	7026	23.82%
Top6 Companies	10147	34.40%